(Q54299767)

27 May 2018

title

Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. (English)

1 reference

27 May 2018

0 references

1 reference

9

Manon van Engeland

1 reference

27 May 2018

Gerrit Meijer

11

object named as

Gerrit A Meijer

1 reference

27 May 2018

author name string

Linda J W Bosch

1

1 reference

27 May 2018

Sandra Mongera

2

1 reference

27 May 2018

Jochim S Terhaar Sive Droste

3

1 reference

27 May 2018

Frank A Oort

4

1 reference

27 May 2018

Sietze T van Turenhout

5

1 reference

27 May 2018

Maarten T Penning

6

1 reference

27 May 2018

Joost Louwagie

7

1 reference

27 May 2018

Chris J J Mulder

8

1 reference

27 May 2018

Beatriz Carvalho

10

1 reference

27 May 2018

publication date

21 July 2012

1 reference

27 May 2018

published in

Cellular Oncology

1 reference

27 May 2018

volume

35

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

309-315

1 reference

27 May 2018

Screening tests for colorectal cancer: a menu of options remains relevant

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Contrasting US and European approaches to colorectal cancer screening: which is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Molecular tests for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

A quantitative immunochemical fecal occult blood test for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Stool DNA and occult blood testing for screen detection of colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Sensitive digital quantification of DNA methylation in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0092-6

A simplified, noninvasive stool DNA test for colorectal cancer detection

21 January 2018

1 reference

12 December 2020

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

1 reference

12 December 2020

Quantification of methylated markers with a multiplex methylation-specific technology

1 reference

12 December 2020

EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens.

1 reference

12 December 2020

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test

1 reference

12 December 2020

DNA quality assessment for array CGH by isothermal whole genome amplification.

1 reference

12 December 2020

Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification.

1 reference

12 December 2020

10.1007/S13402-012-0092-6

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018